Steven Dubovsky, MD
Psychiatry
Professor and Chair; Adjoint Professor of Psychiatry and Medicine, University of Colorado School of Medicine
University at Buffalo - Psychiatry
Erie County Medical Center
462 Grider St. Room 1182
Buffalo, NY 14215
Phone: (716) 898-5940
Fax: 716-898-4538
Email: dubovsky@buffalo.edu
View Map
OFFICE LOCATIONS
|
ECMC 462 Grider Street Buffalo, NY 14215 Phone: 716-898-5940 Fax: 716-898-4538 Email: dubovsky@bufflalo.edu View Map |
DESCRIPTION OF INTERESTS
| Research Interests: Calcium Metabolism in Affective Disorders; Psychopharmacology; Psychosomatic Medicine; Medical Education. Clinical specialties: mood disorders, psychosis, interactions between medical and psychiatric disorders, psychopharmacology, difficult diagnoses, complex clinical entities |
SPECIALTIES
Children and Adults
Psychiatry
Molecular and Cellular Biology
Neuropharmacology
Signal Transduction
LICENSE AND CERTIFICATION
| Certification, American Board of Psychiatry and Neurology, 1975 |
EDUCATION
| 1973 | Residency, Psychiatry University of Colorado Medical Center |
| 1973 | Fellowship, Psychiatry University of Colorado |
| 1970 | Internship, Medicine Vancouver General Hospital |
| 1969 | MD, Medicine New York University School of Medicine |
| 1965 | AB, French Literature New York University Magna Cum Laude Phi Beta Kappa |
EXPERTISE
| Children and Adults; Psychiatry Research Interests: Calcium Metabolism in Affective Disorders; Psychopharmacology; Psychosomatic Medicine; Medical Education. Clinical specialties: mood disorders, psychosis, interactions between medical and psychiatric disorders, psychopharmacology, difficult diagnoses, complex clinical entities. |
PUBLICATIONS
| Dubovsky SL, Frobose C, Phiri P, de Greef R, Panagides J; Short-term safety and pharmacokinetic profile of asenapine in older patients with psychosis.; Int J Geriatr Psychiatry; 2012 May; 27(5); 472-482 |
| Gendel MH, Brooks E, Early SR, Gundersen DC, Dubovsky SL, Dilts SL, Shore JH; Self-prescribed and other informal care provided by physicians: scope, correlations and implications.; J Med Ethics; 2012 Feb; |
| Dubovsky SL, Dubovsky AN; Maintenance treatment of bipolar disorder with ziprasidone in adjunctive use with lithiuim or valproate; Clinical Medicine Insights: Therapeutics; 2012; 4; 1-8 |
| Dubovsky SL, Leonard KE, Griswold K, Daurignac EC, Hewitt B, Fox C, Seymour D, Dubovsky AN, DeGruy F; Bipolar disorder is common in depressed primary care patients.; Postgrad Med; 2011 Sep; 123(5); 129-133 |
| Dubovsky SL, Frobose C, Phiri P, Greef R, Panagides J; Short-term safety and pharmacokinetic profile of asenapine in older patients with psychosis.; Int J Geriatr Psychiatry; 2011 Jul; |
| Dubovsky SL, Dubovsky AN; Ziprasidone for maintenance treatment of bipolar I disorder in adults.; Expert Opin Pharmacother; 2011 Apr; 12(5); 817-824 |
| Dubovsky SL, Tan AR; Dextromethorphan/quinidine for pseudobulbar affect.; Current Psychiatry; 2011; 10; 60-67 |
| Dubovsky SL, Dubovsky AN; Geriatric neuropsychopharmacology. In: Coffey E, Cummings J: Textbook of Geriatric Neuropsychiatry; ; 2011; |
| Dubovsky SL; Review of The Risks of Prescription Drugs Edited by Douglas W Light. Am J Psychiatry; ; 2011; 168; 1124-1125 |
| Dubovsky SL; Review of The Risks of Prescription Drugs Edited By Douglas W. Light; American Journal Psychiatry; 2011; 168; 1124-1125 |
| Dubovsky SL, Warren CG; Are anxiety and panic related to hypertension? in: Toth PP, Sica DA: Clinical Challenges in Hypertension; ; 2010; |
| Dubovsky SL, Kaye DL, Pristach CA, Del Regno P, Pessar L, Stiles K; Can academic departments maintain industry relationships while promoting physician professionalism?; Acad Med; 2010 Jan; 85(1); 68-73 |
| Dubovsky SL, Warren C; Agomelatine, a melatonin agonist with antidepressant properties.; Expert Opin Investig Drugs; 2009 Oct; 18(10); 1533-1540 |
| Dubovsky SL, Dubovsky AN; Psychopharmacology for neurologists.; Semin Neurol; 2009 Jul; 29(3); 200-219 |
| Dubovsky SL; Barbiturates and related drugs. In: Sadock BJ, Sadock VA, Ruiz P: Comprehensive Textbook of Psychiatry, 9th Ed.; ; 2009; |
| Dubovsky SL; Calcium channel inhibitors. In:Sadock BJ, Sadock VA, Ruiz P: Comprehensive Textbook of Psychiatry 9th Ed; ; 2009; |
| Dubovsky SL; Drugs acting on the benzodiazepine receptor. In: Sadock BJ, Sadock VA, Ruiz P: Comprehensive Textbook of Psychiatry, 9th Ed.; ; 2009; |
| Dubovsky SL; Hypertension and psychiatric disorders. In Izzo JL, Sica DA, Black HR (eds): Hypertension Primer, 4th Ed.; ; 2009; |
| Boora K, Chiappone K, Dubovsky SL; Oxcarbazepine-induced reversible anorgasmia and ejaculatory failure: a case report.; Prim Care Companion J Clin Psychiatry; 2009 Jan; 11(4); 173-174 |
| Dubovsky SL, Gendel MH, Dubovsky AN, Levin R, Rosse J, House R; Can admissions interviews predict performance in residency?; Acad Psychiatry; 2008 Nov; 32(6); 498-503 |
| Dubovsky SL, Dubovsky AN; Mood disorders and the outcome of suicidal thoughts and attempts.; Crit Care Clin; 2008 Oct; 24(4); 857-874 |
| Fava GA, Park SK, Dubovsky SL; The mental health clinic: a new model.; World Psychiatry; 2008 Oct; 7(3); 177-181 |
| Mostert MA, Dubovsky SL; When bipolar treatment fails: What‘s your next step?; Current Psychiatry; 2008 Jan; 7; 39-46 |
| Arciniegas DE, Dubovsky SL; Dementia due to other general medical conditions and demential due to multiple etiologies. In: Gabbard GO(ed): Treatments of Psychiatric Disorders; ; 2007; |
| Wolin R., Dubovsky SL, Cowan RB; Depression and neurology. In: Biller J (ed): Neurology and Internal Medicine; ; 2007; |
| Dubovsky SL; Psychotropic Drug Prescriber's Survival Guide: How to Practive Ethically in the Era of Big Pharma; ; 2007; |
| Dubovsky SL, Gendel M, Dubovsky AN, Rosse J, Levin R, House R; Do data obtained from admissions interviews and resident evaluations predict later personal and practice problems?; Acad Psychiatry; 2005 Nov; 29(5); 443-447 |
| Dubovsky SL; Treatment of bipolar depression.; Psychiatr Clin North Am; 2005 Jun; 28(2); 349-370 |
| Dubovsky SL, Tinyakov PG, Tkachev II; Massive graviton as a testable cold-dark-matter candidate.; Phys Rev Lett; 2005 May; 94(18); 181102-181102 |
| Dubovsky SL; Who is teaching psychopharmacology? Who should be teaching psychopharmacology?; Acad Psychiatry; 2005 May; 29(2); 155-161 |
| Dubovsky SL; Clinical Guide to Psychotropic Medications; ; 2005; |
| Dubovsky SL; Enhancing treatment adherence in multiple settings; Primary Psychiatry; 2005; 12; 31-32 |
| Dubovsky SL; Reducing the risk of mania/hypomania associated with stimulant medications; Current Psychiatry; 2005; 4; 36-54 |
| Dubovsky SL; Agents acting on the benzodiazepine receptor. In: Sadock BJ, Sadock VA: Comprehensive Textbook of Psychiatry VIII; ; 2004; |
| Dubovsky SL; Calcium channel inhibitors. In: Sadock BJ, Sadock VA: Comprehensive Textbook of Psychiatry VIII; ; 2004; |
| Dubovsky SL; Group therapy effective for bipolar disorder. Education-based therapy may help avert relapses.; Health News; 2003 Jun; 9(6); 4-4 |
| Feltner, DE, Crockett JG, Dubovsky SL, Cohu, CK,, Shrivastava, RK, Targum, SD, Liu-Dumaw, M, Carter, CM, Pande, AC; A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder; J. Clin Psychopharmacology; 2003; 23(3); 240-249 |
| Dubovsky SL, Dubovsky AN; Concise Guide to Mood Disorders; ; 2002; |
| Dubovsky SL, Davies R, Dubovsky AN; Mood Disorders. In: Hales RE, Yudofsky SC, Talbott JA: American Psychiatric Press Textbook of Psychiatry; ; 2002; |
| Maxmen JS, Ward NG, Dubovsky SL(special consultant); Psychotropic Drugs Fast Facts, Third Edition; ; 2002; |
| Dubovsky SL; Rapid cycling bipolar disease: new concepts and treatments.; Curr Psychiatry Rep; 2001 Dec; 3(6); 451-462 |
| Dubovsky SL, Buzan R, Thomas M, Kassner C, Cullum CM; Nicardipine improves the antidepressant action of ECT but does not improve cognition.; J ECT; 2001 Mar; 17(1); 3-10 |
| Dubovsky SL; Current approaches to the treatment of rapid cycling bipolar disease; Current Psychiatry Reports; 2001; 3; 451-462 |
| Arcinegas D, Dubovsky SL; Other Forms of Dementia. In: Gabbard GO(ed): Treatment of Psychiatric Disorders (3rd Ed); ; 2001; |
| Dubovsky SL, Tinyakov PG, Tkachev II; Statistics of clustering of ultrahigh energy cosmic rays and the number of their sources.; Phys Rev Lett; 2000 Aug; 85(6); 1154-1157 |
| Dubovsky SL; Are antidepressants addictive?; Health News; 2000 Feb; 6(2); 10-10 |
| Salbenblatt MJ, Buzan RD, Dubovsky SL; Risperidone treatment for psychosis in end-stage Friedreich's ataxia.; Am J Psychiatry; 2000 Feb; 157(2); 303-303 |
| Dubovsky SL; Duration of antidepressant treatment and risk of relapse or recurrence; Directions in Psychiatry; 2000; 20; 115-126 |
| Dubovsky SL, Buzan R; Psychopharmacology. In: Coffee CE, Cummings JL: Textbook of Geriatric Neuropsychiatry; ; 2000; |
| Davies RD, Dubovsky SL, Gabbert S, Chapman M; Treatment resistance in anxiety disorders.; Bull Menninger Clin; 2000 Jan; 64(3 Sup); 22-36 |
| Dubovsky SL, Group for Advancement of Psychiatry; Healthcare reform and postgraduate psychiatric education: Challenges and solutions.; Academic Psychiatry; 1999; 23; 1-8 |
| Dubovsky SL; Mind, Body and Mood> In: Levinson D, Ponzetti J, Jorgensen P (eds): Encyclopedia of Human Emotions; ; 1999; |
| Dubovsky SL, Buzan RD; Mood Disorders. In: Hales RE, Yudofsky SC, Talbott JA: American Psychiatric Press Textbook of Psychiatry.; ; 1999; |
| Meis, J.L, Noll, E.L., Hevitt, S., Dubovsky SL, Filley, C.; Visuospatial instruction in Alzheimer’s disease.; J. Invest. Med; 1999; 47; 80A |
| Buzan RD, Dubovsky SL; Recurrence of lamotrigine-associated rash with rechallenge.; J Clin Psychiatry; 1998 Feb; 59(2); 87-87 |
| Dubovsky SL; Cost-effective diagnosis and treatment of depression in primary care practice; Primary Care Case Reviews; 1998; 1; 31-45 |
| Dubovsky SL; Dubovsky SL: Calcium channel antagonists as novel treatments for manic depressive disorder. In: Schatzberg AF, Nemeroff CB (eds): American Psychiatric Press Textbook of Psychopharmacology (2nd edition); ; 1998; |
| Giese AA, Thomas MR, Dubovsky SL, Hilty S; The impact of a history of childhood abuse on hospital outcome of affective episodes.; Psychiatr Serv; 1998 Jan; 49(1); 77-81 |
| Buzan RD, Dubovsky SL, Firestone D, Dal Pozzo E; Use of clozapine in 10 mentally retarded adults.; J Neuropsychiatry Clin Neurosci; 1998 Jan; 10(1); 93-95 |
| Thomas MR, Fryer GE, Rosenberg SA, Kassner C, Dubovsky SL, Shore JH; Examining the link between high-volume providers and shorter inpatient stays.; Psychiatr Serv; 1997 Nov; 48(11); 1396-1398 |
| Thomas MR, Fryer GE, Rosenberg SA, Kassner C, Dubovsky SL, Shore JH; High volume inpatient psychiatrists have shorter lengths of stay.; Annals of Clinical Psychiatry; 1997 Sep; 9(3); 139-143 |
| Thomas MR, Kassner CT, Fryer GE, Giese AA, Rosenberg SA, Dubovsky SL; Impact of shorter lengths of stay on status at discharge in bipolar mania.; Ann Clin Psychiatry; 1997 Sep; 9(3); 139-143 |
| Dubovsky SL, Buzan RD; Novel alternatives and supplements to lithium and anticonvulsants for bipolar affective disorder.; J Clin Psychiatry; 1997 May; 58(5); 224-242 |
| Giese AA, Thomas MR, Dubovsky SL; Dissociative symptoms in psychotic mood disorders: an example of symptom nonspecificity.; Psychiatry; 1997 Jan; 60(1); 60-66 |
| Dubovsky SL; Mind-Body Deceptions; ; 1997; |
| Weintraub P., Dubovsky SL; Pharmacologic treatment of depression in adolescents.; Resident and Staff Physician; 1997; 43; 54-56 |
| Dubovsky SL; Selected issues in the psychopharmacologic treatment of women with psychiatric disorders.; Journal of Practical Psychiatry; 1997; 3; 275-284 |
| Thomas MR, Stoyva J, Rosenberg SA, Kassner C, Fryer GE, Giese AA, Dubovsky SL; Selection bias in an inpatient outcomes monitoring project.; Gen Hosp Psychiatry; 1997 Jan; 19(1); 56-61 |
| Thomas MR, Rosenberg SA, Giese AA, Fryer GE, Dubovsky SL, Shore JH; Shortening length of stay without increasing recidivism on a university-affiliated inpatient unit.; Psychiatr Serv; 1996 Sep; 47(9); 996-998 |
| Dubovsky SL, Thomas M; Tardive dyskinesia associated with fluoxetine.; Psychiatr Serv; 1996 Sep; 47(9); 991-993 |
| Thomas MR, Dubovsky SL, Cox-Young B; Impact of external versus internal case managers on hospital utilization.; Psychiatr Serv; 1996 Jun; 47(6); 593-595 |
| Dubovsky SL; Anxiety Disorders. In. Scully JH (ed):Psychiatry (3rd Ed.); ; 1996; |
| Dubovsky SL, Thomas M; Approaches to the treatment of refractory depression.; J Prac Psychiatry Behav Health; 1996; 2; 14-22 |
| Dubovsky SL, Thomas M; Concepts and treatment strategies for double depression. In: Hales RE, Yudofsky SC (eds): Practical Clinical Strategies in Treating Depression and Anxiety in a Managed Care Environment.; ; 1996; |
| Filley CM, Chapman MM, Dubovsky SL; Ethical concerns in the use of palliative drug treatment for Alzheimer‘s Disease.; J Neuropsychiatry Clin Neurosci; 1996 Jan; 8(2); 202-205 |
| Dubovsky SL; Substance-Related Disorders. In: Scully JH (ed): Psychiatry (3rd Ed.); ; 1996; |
| Buzan RD, Firestone D, Thomas M, Dubovsky SL; Valproate-associated pancreatitis and cholecystitis in six mentally retarded adults.; J Clin Psychiatry; 1995 Nov; 56(11); 529-532 |
| Dubovsky SL, Thomas M; Beyond specificity: effects of serotonin and serotonergic treatments on psychobiological dysfunction.; J Psychosom Res; 1995 May; 39(4); 429-444 |
| Buzan RD, Dubovsky SL, Treadway JT, Thomas M; Opiate antagonists for recurrent self-injurious behavior in three mentally retarded adults.; Psychiatr Serv; 1995 May; 46(5); 511-512 |
| Dubovsky SL; Anxiety Disorders. In: Scully JH (ed): Psychiatry (Second Edition).; ; 1995; |
| Dubovsky SL; Calcium channel antagonists as novel treatments for manic depressive disorder. In: Schatzberg AF, Nemeroff CB (eds): American Psychiatric Press Textbook of Psychopharmacology; ; 1995; |
| Dubovsky SL, Butler LD; Casebook and Study Guide. Abnormal Psychology, Third Edition; ; 1995; |
| Dubovsky SL; Dementia due to other general medical conditions and dementia due to multiple etiologies. In: Gabbard GO (ed): Treatment of Psychiatric Disorders, Second Edition.; ; 1995; |
| Dubovsky SL, Thomas M; Serotonergic mechanisms and current and future psychiatric practice.; J Clin Psychiatry; 1995 Jan; 56 Su; 38-48 |
| Dubovsky SL; Substance-Related Disorders. In: Scully JH (ed): Psychiatry (Second Edition).; ; 1995; |
| Dubovsky SL, Buzan R; The role of calcium channel blockers in the treatment of psychiatric disorders.; CNS Drugs; 1995; 4; 47-57 |
| Buzan RD, Thomas M, Dubovsky SL, Treadway J; The use of opiate antagonists for recurrent self-injurious behavior.; J Neuropsychiatry Clin Neurosci; 1995 Jan; 7(4); 437-444 |
| Dubovsky SL; Beyond the serotonin reuptake inhibitors: rationales for the development of new serotonergic agents.; J Clin Psychiatry; 1994 Feb; 55 Su; 34-44 |
| Dubovsky SL; Why don‘t we hear more about the calcium antagonists? An industry-academia interaction.; Biol Psychiatry; 1994 Feb; 35(3); 149-150 |
| Dubovsky SL; Challenges and concepts in psychotic mood disorders; Bull Menn Clinic; 1994; 58; 197-214 |
| Dubovsky SL; Challenges in conceptualizing psychotic mood disorders.; Bull Menninger Clin; 1994 Jan; 58(2); 197-214 |
| Dubovsky SL, Thomas M, Murphy J, Hijazi A; Characterization of the increased intracellular calcium ion concentration in peripheral cells of bipolar patients and the normalization of intracellular calcium ion concentration by lithium and carbavazepine; Eur Arch Psychiatry Clin Neurosci; 1994; 243; 229-234 |
| Dubovsky SL; Electroconvulsive therapy. In: Kaplan H, Sadock B (eds): Comprehensive Textbook of Psychiatry. Sixth Edition, Volume 2.; ; 1994; |
| Dubovsky SL; Geriatric neuropsychopharmacology. In: Coffey CE, Cummings JL (eds): Textbook of Geriatric Neuropsychiatry.; ; 1994; |
| Dubovsky SL, Thomas M, Hijazi A, Murphy J; Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder.; Eur Arch Psychiatry Clin Neurosci; 1994 Jan; 243(5); 229-234 |
| Dubovsky SL; Approaches to developing new anxiolytics and antidepressants.; J Clin Psychiatry; 1993 May; 54 Su; 75-83 |
| Dubovsky SL; Calcium antagonists in manic-depressive illness.; Neuropsychobiology; 1993 Jan; 27(3); 184-192 |
| Dubovsky SL; Diagnosis and management of psychotic depression.; Directions in Psychiatry; 1993; 13(18); 1-8 |
| Dubovsky SL, Thomas M; Psychotic depression: advances in conceptualization and treatment.; Hosp Community Psychiatry; 1992 Dec; 43(12); 1189-1198 |
| Dubovsky SL, Murphy J, Thomas M, Rademacher J; Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients.; Am J Psychiatry; 1992 Jan; 149(1); 118-120 |
| Dubovsky SL, Murphy J, Christiano J, Lee C; The calcium second messenger system in bipolar disorders: data supporting new research directions.; J Neuropsychiatry Clin Neurosci; 1992 Jan; 4(1); 3-14 |
| Dubovsky SL; Recognizing and treating depression and anxiety; Med Aspects Hum Sexuality; 1991 Oct; |
| Dubovsky SL; What we don‘t know about psychotic depression.; Biol Psychiatry; 1991 Sep; 30(6); 533-536 |
| Dubovsky SL, Lee C, Christiano J, Murphy J; Elevated platelet intracellular calcium concentration in bipolar depression.; Biol Psychiatry; 1991 Mar; 29(5); 441-450 |
| Hofmann DP, Dubovsky SL; Depression and suicide assessment.; Emerg Med Clin North Am; 1991 Feb; 9(1); 107-121 |
| Dubovsky SL; Electroconvulsive therapy as a probe of the boundaries of neuropsychiatry.; J Neuropsychiatry Clin Neurosci; 1991 Jan; 3(4); 361-363 |
| Dubovsky SL, Lee C, Christiano J, Murphy J; Lithium lowers platelet intracellular calcium levels in bipolar patients.; Lithium; 1991; 2; 167-174 |
| Dubovsky SL; Psychopharmacologic treatment in neuropsychiatry. In: Hales RE, Yudofsky SC (eds): Textbook of Neuropsychiatry (Second Edition); ; 1991; |
| Dubovsky SL; Understanding and treating depression in anxious patients.; J Clin Psychiatry; 1990 Oct; 51 Su; 3-8 |
| Dubovsky SL, Scully JH; Hazards of long-term psychotherapy during psychiatric residency.; Psychiatry; 1990 May; 53(2); 185-194 |
| Dubovsky SL; Generalized anxiety disorder: new concepts and psychopharmacologic therapies.; J Clin Psychiatry; 1990 Jan; 51 Su; 3-10 |
| Dubovsky SL, Scully J; Response to Simon; Psychiatry; 1990; 53; 198-199 |
| Dubovsky SL, Christiano J, Daniell LC, Franks RD, Murphy J, Adler L, Baker N, Harris RA; Increased platelet intracellular calcium concentration in patients with bipolar affective disorders.; Arch Gen Psychiatry; 1989 Jul; 46(7); 632-638 |
| Dubovsky SL; Anxiety. In: Scully, J.H. (ed): Psychiatry. Philadelphia, Harwal Publishing Co.; ; 1988; |
| Dubovsky SL; Concise Guide to Clinical Psychiatry; ; 1988; |
| Dubovsky SL, Freed C; Exercise-induced bronchospasm caused by maprotiline.; Psychosomatics; 1988 Jan; 29(1); 104-106 |
| Dubovsky SL; Psychiatric Applications of Calcium Channel Blocking Drugs.; Tod Ther Trends; 1988; 6; 59-75 |
| Scully JH, Dubovsky SL; Psychiatric disorders. In: Schrier, RW(ed): Medicine: Diagnosis and Treatment; ; 1988; |
| Dubovsky SL; Substance related disorders. In: Scully, J.H. (ed): Psychiatry. Philadelphia, Harwal Publishing Co.; ; 1988; |
| Dubovsky SL, Franks RD, Allen S; Verapamil: a new antimanic drug with potential interactions with lithium.; J Clin Psychiatry; 1987 Sep; 48(9); 371-372 |
| Dubovsky SL; Severe nortriptyline intoxication due to change from a generic to a trade preparation.; J Nerv Ment Dis; 1987 Feb; 175(2); 115-117 |
| Dubovsky SL, Katz JL, Scherger JE, Uhde TW; Anxiolytics: When? Why? Which one?; Patient Care; 1987; 21; 60-81 |
| Dubovsky SL; Intracellular calcium in affective disorders; Dir Psychiatry; 1987; 7; 1-7 |
| Dubovsky SL, Ringel SP; Psychopharmacologic treatment in neurological practice.; J Neurol Rehab; 1987; 2; 51-66 |
| Dubovsky SL; Psychopharmacologic treatment in neuropsychiatry. In: Hales RE, Yudofsky S.C. (eds): Textbook of Neuropsychiatry; ; 1987; |
| Dubovsky SL; Unusual faces of depression: recognizing and treating complicated and atypical depressive syndromes.; Therapeutic Strategies in Depression; 1987; 1; 3-14 |
| Dubovsky SL; Coping with entitlement in medical education.; N Engl J Med; 1986 Dec; 315(26); 1672-1674 |
| Dubovsky SL, Franks RD, Allen S, Murphy J; Calcium antagonists in mania: a double-blind study of verapamil.; Psychiatry Res; 1986 Aug; 18(4); 309-320 |
| Dubovsky SL; Using electroconvulsive therapy for patients with neurological disease.; Hosp Community Psychiatry; 1986 Aug; 37(8); 819-825 |
| Dubovsky SL; Calcium antagonists: a new class of psychiatric drugs?; Psychiatry Ann; 1986; 16; 724-728 |
| Dubovsky SL, Weissberg MP; Clinical Psychiatry in Primary Care (3rd Ed) (Also published in Spanish and Japanese); ; 1986; |
| Dubovsky SL; Intracellular calcium in affective disorders: Evidence in favor of deranged dynamics.; Dev Psychiatry; 1986; 7; 317-319 |
| Metzner JL, Dubovsky SL; The role of the psychiatrist in evaluating a prison mental health system in litigation.; Bull Am Acad Psychiatry Law; 1986 Jan; 14(1); 89-95 |
| Dubovsky SL, Gay M, Franks RD, Haddenhorst A; ECT in the presence of increased intracranial pressure and respiratory failure: case report.; J Clin Psychiatry; 1985 Nov; 46(11); 489-491 |
| Dubovsky SL, Franks RD, Schrier D; Phenelzine-induced hypomania: effect of verapamil.; Biol Psychiatry; 1985 Sep; 20(9); 1009-1014 |
| Dubovsky SL, Haddenhorst A, Murphy J, Liechty RD, Coyle DA; A preliminary study of the relationship between preoperative depression and weight loss following surgery for morbid obesity.; Int J Psychiatry Med; 1985 Jan; 15(2); 185-196 |
| Dubovsky SL, Gay M, Haddenhorst A, Franks R; Electroconvulsive therapy in the presence of increased intracranial pressure and respiratory failure.; J Clin Psychiatry; 1985; 46; 489-491 |
| Dubovsky SL, Liechty RD; Psychiatric evaluation in gastric surgery for obesity.; Psychother Psychosom; 1985 Jan; 44(3); 144-150 |
| Dubovsky SL; Review of R. Waldinger, Psychiatry for Medical Students; Psychosomatics; 1985; 26; 258-259 |
| Dubovsky SL; The anesthesiologist and the drug abuser; Human Aspects of Anesthesiology (In Press); 1985; |
| Dubovsky SL; The psychophysiology of stress, illness and health. In: Simons RC (ed): Understanding Human Behavior (3rd Ed).; ; 1985; |
| Dubovsky SL; Acute drug and alcohol syndromes. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making.; ; 1984; |
| Dubovsky SL; Acute psychiatric problems related to trauma. In: Eiseman B, Moore E, Van Way C (Eds): Care of the Injured--A Practical Guide.; ; 1984; |
| Dubovsky SL; Agitation. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making; ; 1984; |
| Dubovsky SL; Chronic severe self-destructive behavior. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making; ; 1984; |
| Dubovsky SL; Couples therapy. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making. St.; ; 1984; |
| Dubovsky SL; Drug intoxication. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making; ; 1984; |
| Weston JA, Dubovsky SL; Evaluating medical school graduates of a reduced course program: a preliminary report.; J Med Educ; 1984 Jan; 59(1); 1-6 |
| Dubovsky SL; First-line drugs used to treat depression. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making; ; 1984; |
| Dubovsky SL; How to Involve Patients in Medical Decisions; Physician and Patient; 1984; 3; 54-61 |
| Dubovsky SL (Ed); Insight into Depression and Suicide: A Perspective for the Primary Care Physician; ; 1984; |
| Dubovsky SL; Lithium carbonate. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making.; ; 1984; |
| Dubovsky SL; New antidepressants. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making.; ; 1984; |
| Dubovsky SL; Psychiatric and sexual disorders. In: Schrier RW(ed): Current Medical Therapy.; ; 1984; |
| Dubovsky SL, Feiger A, Eiseman B (Eds); Psychiatric Decision Making; ; 1984; |
| Dubovsky SL; Review of Psychiatric Management for Medical Practitioners, edited by Donald S. Kornfeld and Jerry B. Finkel; Psychosomatics; 1984; 25; 340-341 |
| Dubovsky SL; Sadness, unhappiness, misery. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making; ; 1984; |
| Dubovsky SL; Second-line drugs used to treat depression. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making; ; 1984; |
| Dubovsky SL; The angry patient. In: Robertson D(ed): Principles of Family Medicine.; ; 1984; |
| Dubovsky SL; The suicidal patient. In: Norton LW, Eiseman, B(eds): Surgical Decision Making (2nd Ed).; ; 1984; |
| Dubovsky SL; The therapist-patient relationship in chronic care. In: Maloney LP, Burks J, Ringel SP(eds): The Interdisciplinary Rehabilitation of MS & Neuromuscular Disease; ; 1984; |
| Dubovsky SL; The threatening or frightening patient. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making; ; 1984; |
| Dubovsky SL, Schrier RW; The mystique of medical training.; JAMA; 1983 Dec; 250(22); 3057-3058 |
| Dubovsky SL; Psychiatry in Saudi Arabia.; Am J Psychiatry; 1983 Nov; 140(11); 1455-1459 |
| House R, Dubovsky SL, Penn I; Psychiatric aspects of hepatic transplantation.; Transplantation; 1983 Aug; 36(2); 146-150 |
| Dubovsky SL, Franks RD; Intracellular calcium ions in affective disorders: a review and an hypothesis.; Biol Psychiatry; 1983 Jul; 18(7); 781-797 |
| Scully JH, Dubovsky SL, Simons RC; Undergraduate education and recruitment into psychiatry.; Am J Psychiatry; 1983 May; 140(5); 573-576 |
| Dubovsky SL; "Talk therapy" in primary care: Realistic parameters; Physician and Patient; 1983; 2; 35-45 |
| Dubovsky SL; Psychiatric approach to high risk obstetrics. In: Abrams R, Wexler P(eds): Medical Problems During Pregnancy; ; 1983; |
| Franks RD, Dubovsky SL, Lifshitz M, Coen P, Subryan V, Walker SH; Long-term lithium carbonate therapy causes hyperparathyroidism.; Arch Gen Psychiatry; 1982 Sep; 39(9); 1074-1077 |
| Good WV, Dubovsky SL; Pseudodementia masking substance abuse and depression.; Psychosomatics; 1982 Jun; 23(6); 652-657 |
| Dubovsky SL, Franks RD, Lifschitz M, Coen P; Effectiveness of verapamil in the treatment of a manic patient.; Am J Psychiatry; 1982 Apr; 139(4); 502-504 |
| Dubovsky SL, Weissberg MB; Clinical Psychiatry in Primary Care: 2nd Edition; ; 1982; |
| Dubovsky SL, Franks RD, Lifschitz ML, Coen P, Walker SH, Subryan V; Hypocalciuric effect of lithium: a confirmatory study.; Psychoneuroendocrinology; 1982 Jan; 7(4); 355-359 |
| Dubovsky SL; Psychiatric Problems in Neurological Practice; ; 1982; |
| Dubovsky SL; Psychological Management in Neurological Practice; ; 1982; |
| Dubovsky SL, Dilts SL; Psychiatric Problems in Family Practice; ; 1981; |
| Dubovsky SL; Psychiatric Problems in Primary Practice (series of 6 monographs); ; 1981; |
| Dubovsky SL, Dilts SL; Psychological Management in Family Practice; ; 1981; |
| Dubovsky SL (Ed); Psychological Management in Medical Practice (series of 6 monographs); ; 1981; |
| Dubovsky SL; Psychotherapeutics in Primary Care; ; 1981; |
| Dubovsky SL; The psychophysiology of stress, illness and health. In: Simons RC, Pardes H(eds): Understanding Human Behavior (2nd Ed); ; 1981; |
| Dubovsky SL, Penn I; Psychiatric considerations in renal transplant surgery.; Psychosomatics; 1980 Jun; 21(6); 481-491 |
| Dubovsky SL; Psychiatric considerations in transplant surgery. In: Guerra F, Aldrete JA(eds): Emotional Responses to Anesthesia and Surgery; ; 1980; |
| Dubovsky SL; Suicide. In: Eiseman B (Ed): Prognosis in Surgical Disease; ; 1980; |
| Dubovsky SL, Penn I; The stress of organ transplantation; ; 1980 Jan; 1; 20-26 |
| Dubovsky SL, Metzner JL, Warner RB; Problems with internalization of a transplanted liver.; Am J Psychiatry; 1979 Aug; 136(8); 1090-1091 |
| Miller PD, Dubovsky SL, McDonald KM, Katz FH, Robertson GL, Schrier RW; Central, renal and adrenal effects of lithium in man.; Am J Med; 1979 May; 66(5); 797-803 |
| Dubovsky SL; "Experimental" self-mutilation.; Am J Psychiatry; 1978 Oct; 135(10); 1240-1241 |
| Dubovsky SL; Averting suicide in terminally ill patients.; Psychosomatics; 1978 Feb; 19(2); 113-115 |
| Dubovsky SL; Clinical Psychiatry in Primary Care; ; 1978; |
| Miller P, Dubovsky SL, McDonald KM, Arnaud C, Schrier RW; Hypocalciuric effect of lithium in man; Mineral Electrolyte Metab; 1978; 1; 3-11 |
| Weissberg MP, Dubovsky SL; Assessment of psychiatric emergencies in medical practice.; Prim Care; 1977 Dec; 4(4); 651-660 |
| Dubovsky SL, Getto CJ, Gross SA, Paley JA; Impact on nursing care and mortality: psychiatrists on the coronary care unit.; Psychosomatics; 1977 Aug; 18(3); 18-27 |
| Trustman R, Dubovsky SL, Titely R; Audiotry perception during general anesthesia; Int J Clin Exp Hypn; 1977; 25; 88-151 |
| Miller PD, Dubovsky SL, Schrier RW, McDonald KM, Arnaud C; Hypocalciuric effect of lithium in man.; Adv Exp Med Biol; 1977 Jan; 81; 157-172 |
| Dubovsky SL, Trustman R; Absence of recall after general anesthesia: implications for theory and practice.; Anesth Analg; 1976 Sep; 55(5); 696-701 |
| Dubovsky SL; Current concepts in the differential diagnosis and treatment of depression. In: Cozzetto FC, Brettell HR (Eds.): Topics in Family Practice; ; 1976; |
| Dubovsky S, Miller PD, MacDonald KM, Schrier RW; Hypocalciuric effect of Lithium (Li)in man; Clin Res; 1976; 24; 156A |
| Dubovsky SL, Groban SE; Congenital absence of sensation.; Psychoanal Study Child; 1975 Jan; 30; 49-73 |
| Dubovsky SL, Plummer S, Ringer L; The suicidal and terminally ill patient; Ostomy Quart; 1975; 12; 52-54 |
| Dubovsky SL, Groban S, Berl T, Schrier RW; Letter: Water intoxication and psychosis. In comment.; Ann Intern Med; 1974 Feb; 80(2); 281-282 |
| Dubovsky SL, Grabon S, Berl T, Schrier RW; Syndrome of inappropriate secretion of antidiuretic hormone with exacerbated psychosis.; Ann Intern Med; 1973 Oct; 79(4); 551-554 |
| Dubovsky SL, Shore JH (eds); Current Therapy in Psychiatry; |
GRANTS
January 2012 to January 2014
A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance treatment of subjects with schizophrenia (D1050238). Sunovion
Steven Dubovsky
$200,000
January 2011 to January 2013
A 6-month, open-label,multicenter, flexible-dose extension study to the B2061032 study to evaluate the safety, tolerability &efficacy of desvenlafaxine succinate sustained-release (dvs sr) tablets in the treatment of children & adolescent patient. Pfizer
Steven Dubovsky
$200,000
January 2011 to January 2013
A Fifteen-Month, Prospective, Randomized, Active-Controlled, Open-Label, Flexible-Dose Study of Paliperidone Palmitate Compared with Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults with Schizophrenia Who Have Been Incarcerate
Janssen
Steven Dubovsky
$74,000
January 2011 to January 2013
A fifteen-month, prospective, randomized, active-controlled, open-label, flexible-dose study of paliperidone palmitate compared with oral antipsychotic treatment in delaying time to treatment failure in adults with schizophrenia. Ortho McNeil Janssen
Ortho McNeil Janssen
Steven Dubovsky
$150,000
January 2011 to January 2014
A long-term, multicenter, open-label study to evaluate the safety and tolerability of flexible-dose oral aripiprazole (OPC-14597) as maintenance treatment in adolescent patients with schizophrenia or child and adolescent patients with bipolar I disorder,
Otsuka
Steven Dubovsky
$150,000
January 2011 to January 2012
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients with DSM-IV-TR Schizophrenia. Lilly
Steven Dubovsky
$645,000
January 2011 to January 2014
A long-term, Phase 3, multicenter, open-label trial to evaluate the safety and tolerability of oral OPC-34712 as maintenance treatment in adults with schizophrenia. Otsuka
Steven Dubovsky
$150,000
January 2011 to January 2015
A multicenter, open-label study to assess hospitalization rates in adult subjects with schizophrenia treated prospectively for 6 months with aripiprazole IM depot compared with 6-month retrospective treatment with oral antipsychotic in a naturalistic com
Otsuka
Steven Dubovsky
$150,000
January 2011 to January 2013
A Multicenter, Open-label Study to Assess Hospitalization Rates in Adult Subjects with Schizophrenia Treated Prospectively for 6 Months with Aripiprazole IM Depot compared with 6-month Retrospective Treatment with Oral Antipsychotics in a Naturalistic Co
Otskuka
Steven Dubovsky
$200,000
January 2011 to January 2012
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III, Long-Term Safety and Tolerability Study of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant in Patients with Major Depressive Disorder Who Exhibit an Inade
Astra Zeneca
Steven Dubovsky
$75,000
January 2011 to January 2012
A phase 3, long-term, open-label, flexible dose, extension study evaluating the safety and tolerability of LuAA21004 (15 and 20mg) in subjects with major depressive disorder. Takeda
Steven Dubovsky
$175,000
January 2011 to January 2013
A Phase 3, multicenter, double-blind, placebo-controlled study of 3 doses of LY2140023 monohydrate in the acute treatment of patients with DSM-IV-TR schizophrenia. Lilly
Lilly
Steven Dubovsky
$174,000
January 2011 to January 2012
A Phase III, multi-center, randomized, 12 week, double-blind, parallel group, placebo-controlled study to evaluate efficacy and safety of R04917838 in patients with sup-optimally controlled symptoms of schizophrenia. Genotech
Steven Dubovsky
$150,000
January 2010 to January 2013
A long-term, multicenter, open-label study to evaluate the safety and tolerability of flexible-dose oral aripiprazole (OPC-14597) as maintenance treatment in adolescent patients with schizophrenia (31-09-267). Otsuka:
Steven Dubovsky
$150,000
January 2010 to January 2011
A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Phase III, Efficacy and Safety Study of 3 Fixed Dose Groups of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant in Patients with Major Depressive Disorder Who Exhibit
Astra Zeneca
Steven Dubovsky
$100,000
January 2010 to January 2012
A Randomized Phase 2A, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of CP-601,927 Augmentation of Antidepressant Therapy in Major Depression (A3331017). Pfizer
Steven Dubovsky
$150,000
January 2010 to January 2011
Four week, double-blind, placebo controlled phase III trial evaluating the efficacy, safety and pharmacokinetics of flexible doses of oral ziprasidone in children and adolescents with bipolar I disorder. Pfizer
Pfizer
Steven Dubovsky
$75,000
January 2010 to January 2012
International, multicenter, study of a twenty-eight week, open-label, titrated oral lixivaptan administration in patients with chronic hyponatremia: Extension to studies CK-LX3401, 3405, and 3430 (CK-LX3431). Cardiokine
Steven Dubovsky
$150,000
January 2010 to January 2012
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subjects with Euvolemic Hyponatremia (CK-LX3405). Cardiokine
Steven Dubovsky
$75,000
January 2010 to January 2013
Open-label, multicenter, rollover, long-term study of aripiprazole intramuscular depot in patients with schizophrenia (31-10-270). Otsuka:
Steven Dubovsky
$150,000
January 2010 to January 2011
Randomized phase 2A, double-blind, placebo-controlled study of the efficacy and safety of CP-601,927 augmentation of antidepressant therapy in major depression. Pfizer
Pfizer
Steven Dubovsky
$100,000
January 2009 to January 2010
Antidepressant impact of lurasidone in bipolar depression.
Sumitomo Pharma
Steven Dubovsky
$250,000
January 2009 to January 2010
Multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and tolerability of oral lixivaptan capsules in subjects with euvolemic hyponatremia.
Cardiokine
Steven Dubovsky
$75,000
January 2009 to January 2011
Phase 3, multi-center, randomized, double-blind placebo-controlled study to evaluate the safety and tolerability of dimebon (PF-01913539) for up to 26-weeks in patients with mild to moderate Alzheimer's disease.
Pfizer
Steven Dubovsky
$150,000
January 2008 to December 2009
A 12-week, multicenter, open label study to evaluate the effectiveness and safety of donepezil hydrochloride (E2020) in subjects with mild to severe Alzheimer’s disease residing in an assisted living facility. Esai
Steven Dubovsky
$150,000
January 2008 to January 2010
A 52-week, multicenter, double-blind, placebo-controlled study to evaluate the safety, efficacy and tolerability of an intramuscular depot formulation of aripiprazole as maintenance treatment in patients with schizophrenia Otsuka
Steven Dubovsky
$125,000
January 2008 to December 2008
A multicenter, double-blind, flexible-dose, 6-month trial comparing the efficacy and safety of asenapine and olanzapine in stable subjects with persistent negative symptoms of schizophrenia. Pfizer
Steven Dubovsky
$100,000
January 2008 to December 2009
Comparison of divalproex plus olanzapine or placebo in mild to moderate mania. Lilly
Steven Dubovsky
$83,920
January 2008 to December 2008
Phase III, randomized, 6-month, double blind trial in subjects with bipolar disorder to evaluate the continued safety and maintenance of effect of ziprasidone plus a mood stabilizer. Pfizer
Steven Dubovsky
$120,000
January 2008 to December 2010
Phase III, randomized, placebo-controlled clinical trial to study the safety and efficacy of 3 doses of lurasidone in acutely psychotic patients with schizophrenia. Sumitomo Pharma
Steven Dubovsky
$250,000
January 2008 to January 2012
Rapid Pediatric Psychiatry Consultation Project. Tower Foundation
Steven Dubovsky
$400,000
January 2007 to December 2008
A 52-week, randomized, double-blind, placebo-controlled, multi-center, parallel-group study of the long-term efficacy, tolerability and safety of agomelatine 25 and 50 mg in the prevention of relapse of Major Depressive Disorder (MDD) following open-labe
Steven Dubovsky
$200,000
January 2007 to January 2009
A randomized, parallel group, multiple dose six-week study to evaluate safety, tolerability and pharmacokinetics of asenapine in elderly patients. Merck
Steven Dubovsky
$150,000
January 2007 to December 2008
A randomized, parallel group, multiple dose, 6-week study to evaluate the safety, tolerability and pharmacokinetics of asenapine in elderly subjects with psychosis. Pfizer: $50,000; 2007-2008
Steven Dubovsky
$100,000
January 2007 to December 2008
A three-week double-blind, multicenter, placebo controlled study evaluating the safety and efficacy of add-on ziprasidone to lithium or divalproex in mania. Pfizer
Steven Dubovsky
$60,000
January 2006 to December 2007
A Multicenter, Double-Blind, Flexible-Dose, 6-Month Trial Comparing the Efficacy and Safety of Asenapine with Olanzapine in Stable Subjects with Predominant, Persistent Negative Symptoms of Schizophrenia. Pfizer:
Steven Dubovsky
$150,000
January 2006 to December 2007
A Phase 3, Randomized, 6-Month, Double Blind Trial in Subjects with Bipolar I Disorder to Evaluate the Continued Safety and Maintenance of Effect of Ziprasidone Plus Mood Stabilizer (vs. Placebo Plus a Mood Stabilizer) Following a Minimum of 4 Months Res
Steven Dubovsky
$250,000
January 2006 to December 2007
A Randomized, Parallel-Group, Multiple Dose, 6-Week Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Asenapine in Elderly Subjects with Psychosis. Janssen:
Steven Dubovsky
$200,000
January 2006 to December 2008
Efficacy of psychiatric consultation to pediatricians treating mental disorders. Tower Foundation:
Steven Dubovsky
$100,000
January 2006 to December 2007
Ziprasidone for adolescent mania. Pfizer
Steven Dubovsky
$210,000
January 2005 to January 2005
Bipolar Disorder in Primary Care
Marcelle Mostert; Dubovsky, S
January 2005 to December 2005
Does levetiracetam lower platelet intracellular calcium ion concentration in bipolar mood disorder? UCB Pharma
Steven Dubovsky
$50,000
January 2005 to December 2006
Extended release memantine in moderate-severe Alzheimer‘s disease. Forest
Steven Dubovsky
$200,000
January 2005 to December 2006
Open-label, flexible-dose, long-term safety and efficacy study of bifeprunox in the treatment of schizophrenia. Solvay
Steven Dubovsky
$100,000
January 2005 to December 2005
Randomized, double-blind, placebo-controlled and risperidone-referenced parallel group efficacy and safety study of two fixed doses of bifeprunox in the treatment of schizophrenia. Solvay
Steven Dubovsky
$150,000
January 2004 to December 2005
Aripiprazole in refractory depression. BMS
Steven Dubovsky
$100,000
January 2004 to December 2004
Paloperidone for schizophrenia. Johnson and Johnson.
Steven Dubovsky
$250,000
January 2004 to December 2004
Prediction of Psychiatric Diagnosis with Brain Imaging Using SPECT. Brain Matters
Steven Dubovsky
$50,000
January 2003 to December 2004
Escitalopram for geriatric depression. Forest
Steven Dubovsky
$150,000
January 2003 to December 2003
Escitalopram for pediatric depression. Forest:
Steven Dubovsky
$150,000
January 2003 to December 2004
Levatiracetam effect on intracellular calcium signaling in bipolar disorder. Pharma
Steven Dubovsky
$50,000
January 2003 to December 2004
Neuramaxane in Alzheimer‘s disease. Forest
Steven Dubovsky
$250,000
January 2003 to December 2004
Neuramaxane plus donepezil in Alzheimer‘s disease. Forest
Steven Dubovsky
$250,000
January 2002 to December 2003
Evaluation of patients with bipolar disorder. Sutherland Foundation
Steven Dubovsky
$49,000
January 2002 to December 2003
Memantine plus donepezil in Alzheimer‘s disease. Forest
Steven Dubovsky
$250,000
January 2002 to December 2003
MK-1 antagonist for major depression. Merck
Steven Dubovsky
$293,000
January 2002 to December 2004
Telemedicine consultation in primary care. Pfizer
Steven Dubovsky
$30,000
January 2001 to December 2002
Ariprazole for psychosis in demented nursing home patients. Bristol Myers Squibb
Steven Dubovsky
$150,000
January 2001 to December 2002
Galantamine in Alzheimer’s disease. Janssen
Steven Dubovsky
$100,000
January 2001 to December 2002
Galantamine in Lewy body disease. Janssen
Steven Dubovsky
$150,000
January 2001 to December 2003
Memantine in Alzheimer‘s disease. Forest
Steven Dubovsky
$200,000
January 2001 to December 2005
NIDA Clinical Trials Network (Paula Riggs, P.I.):
Steven Dubovsky
January 2001 to December 2002
Valproic acid for agitation in demented nursing home patients. Abbott Laboratories
Steven Dubovsky
$100,000
January 2000 to December 2001
5HT1D antagonist in panic disorder. Pfizer
Steven Dubovsky
$150,000
January 2000 to December 2001
CP-448 (5HT1D antagonist) in major depressive disorder. Pfizer
Steven Dubovsky
$150,000
January 2000 to December 2001
Outpatient trial of sertraline in children and adolescents with major depressive disorder. Pfizer
Steven Dubovsky
$97,000
January 1999 to December 2000
Extended study of pregabalin for social phobia. Parke-Davis
Steven Dubovsky
$279,000
January 1999 to December 2000
Fluvoxamine in social phobia. Solvay
Steven Dubovsky
$79,000
January 1999 to December 2000
Injectible olanzapine versus placebo in the treatment of acute mania. Eli Lilly
Steven Dubovsky
$160,000
January 1999 to December 2000
L-deprenyl patch for depression. Somerset
Steven Dubovsky
$109,000
January 1999 to December 2000
Olanzapine versus risperidone in the treatment of agitation and psychosis in demented patients. Lilly
Steven Dubovsky
$150,000
January 1999 to December 2000
Somatostatin analogue in Alzheimer‘s disease. Fugisawa
Steven Dubovsky
$250,000
January 1998 to December 1998
Metrifonate for Alzheimer’s disease: MINT study. Bayer Laboratories
Steven Dubovsky
$30,000
January 1998 to December 1999
Olanzapine in the Reduction of Hyperprolactinermia and associated morbidity in schizophrenic
Steven Dubovsky
$26,500
January 1998 to December 1999
Olanzapine versus risperidone and placebo in the treatment of psychosis and associated behavioral disturbances in patients with dementia. Eli Lilly
Steven Dubovsky
$115,700
January 1998 to December 1999
Placebo Controlled Study of Two Doses of Fluoxetine in Post Traumatic Stress Disorder. Eli Lilly
Steven Dubovsky
$230,000
January 1998 to December 1999
Placebo controlled trial of paroxetine in post traumatic stress disorder. Smith Kline
Steven Dubovsky
$200,000
January 1998 to December 1999
Placebo-Controlled Study of Pregabalin and Lorazepam in Patients with Generalized Anxiety Disorder. Parke-Davis Research
Steven Dubovsky
$456,000
January 1998 to December 1999
Pregabalin for generalized anxiety disorder. Parke-Davis
Steven Dubovsky
$400,000
January 1998 to December 1999
Prevalence of hyperprolactinemia in schizophrenic patients treated with antipsychotic drugs. Eli Lilly
Steven Dubovsky
$24,000
January 1998 to December 1998
Sertraline in Post Traumatic Stress Disorder. Pfizer Laboratories
Steven Dubovsky
$298,000
January 1998 to December 1998
Sertraline in Premenstrual Syndrome. Pfizer Laboratories
Steven Dubovsky
$62,000
January 1998 to December 1999
Substance P inhibitor for major depressive disorder. Novartis
Steven Dubovsky
$250,000
January 1998 to December 1999
Substance P inhibitor for social phobia. Novartis
Steven Dubovsky
$250,000
January 1997 to December 1998
Exelon for Alzheimer’s Disease, Novartis
Steven Dubovsky
$200,000
January 1996 to December 1997
E2020 (Donepezil) in Alzheimer’s Disease, Esai/Pfizer Laboratories
Steven Dubovsky
$260,000
January 1994 to December 1995
Metrifonate in Alzheimer‘s disease, Miles Laboratories
Steven Dubovsky
$375,000
January 1994 to December 1995
Physostigmine Extended Release in Alzheimer‘s disease, Forrest
Steven Dubovsky
$320,000
January 1988 to December 1990
Nimodipine in Alzheimer‘s disease, Miles Laboratories
Steven Dubovsky
$220,000
January 1979 to December 1982
5-D18-MB0035 BHM HRA
BHM HRA
Steven Dubovsky
$492,000
January 1977 to December 1982
MH l45l7, NIMH
Steven Dubovsky, $255,000
$255,000